RE: ASCO Poster4 Aug 2024 00:31
“11/13 patients had a RECIST 1.1 objective response an
85% ORR, see figure 4.
• All patients imaged beyond week 13 showed a
sustained shrinkage of their target lesions, see figure 5.
All
patients had metastatic (stage IV) unresectable melanoma.
The predominant site of metastases is the lung (n=6), but
patients also entered the study with metastases in the liver,
distant nodes or musculoskeletal. Two patients had
metastases in both the liver and the lung.”